Comparison of standard-dose and low-dose gemcitabine regimens in pancreatic adenocarcinoma patients: a prospective randomized trial.

Source:http://linkedlifedata.com/resource/pubmed/id/16501860

Download in:

View as

General Info

PMID
16501860